Glycine agonists what can they teach us about schizophrenia?

Archives of General Psychiatry

Volumn 56, Issue 1, 1999, Pages 13-17

  Farber, N B ^a   Newcomer, J W ^a   Olney, J W ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSERINE; FENCLONINE; GLUTAMIC ACID; GLYCINE; GLYCINE DERIVATIVE; KETAMINE; LAMOTRIGINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; OLANZAPINE; PSYCHOTROPIC AGENT;

BRAIN PROTECTION; CLINICAL TRIAL; DISEASE MODEL; DRUG EFFECT; GABAERGIC TRANSMISSION; HUMAN; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; NOTE; PSYCHOPHARMACOTHERAPY; SCHIZOPHRENIA;

EID: 0032901695     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.56.1.13     Document Type: Note

References (50)